- Report
- November 2022
- 218 Pages
Global
From €3125EUR$3,600USD£2,709GBP
- Report
- October 2025
- 89 Pages
Oman
From €4210EUR$4,850USD£3,650GBP
- Report
- October 2025
- 90 Pages
Kuwait
From €4210EUR$4,850USD£3,650GBP
- Report
- June 2025
- 158 Pages
Canada
From €4336EUR$4,995USD£3,759GBP
- Report
- September 2024
- 87 Pages
Global
From €3472EUR$4,000USD£3,010GBP
- Report
- April 2023
- 192 Pages
North America
From €6935EUR$7,990USD£6,013GBP
- Report
- April 2023
- 306 Pages
Europe
From €6935EUR$7,990USD£6,013GBP
- Report
- April 2023
- 306 Pages
Asia Pacific
From €6935EUR$7,990USD£6,013GBP
- Report
- March 2023
- 71 Pages
Canada
From €2600EUR$2,995USD£2,254GBP
- Report
- March 2023
- 71 Pages
Australia
From €2600EUR$2,995USD£2,254GBP
- Report
- March 2023
- 71 Pages
India
From €2600EUR$2,995USD£2,254GBP
- Report
- March 2023
- 71 Pages
Germany
From €2600EUR$2,995USD£2,254GBP
- Database
- February 2023
Canada
From €6510EUR$7,500USD£5,644GBP
- Database
- July 2020
France
From €6510EUR$7,500USD£5,644GBP
- Report
- June 2020
- 464 Pages
Global
From €4253EUR$4,900USD£3,688GBP
- Report
- April 2020
- 71 Pages
Global
From €5208EUR$6,000USD£4,515GBP
- Report
- November 2018
- 98 Pages
Latin America
From €6510EUR$7,500USD£5,644GBP
- Database
- October 2018
Malaysia
€6510EUR$7,500USD£5,644GBP
From €3038EUR$3,500USD£2,634GBP
- Report
- October 2023
- 146 Pages
Global
From €3602EUR$4,150USD£3,123GBP

The biopsy market within the context of In Vitro Diagnostics (IVD) is a segment of the healthcare industry that focuses on the diagnosis of diseases and conditions through the analysis of biological samples. Biopsy tests are used to detect a wide range of conditions, including cancer, infections, and autoimmune diseases. The biopsy market is composed of a variety of products and services, including biopsy needles, biopsy forceps, biopsy punches, and biopsy kits. These products are used to collect tissue samples from patients for further analysis.
The biopsy market is driven by the increasing prevalence of chronic diseases, the growing demand for personalized medicine, and the development of advanced technologies. Additionally, the increasing adoption of minimally invasive procedures and the rising demand for cost-effective diagnostic solutions are expected to drive the growth of the biopsy market.
Some of the major companies in the biopsy market include Becton Dickinson, Cook Medical, Olympus Corporation, Stryker Corporation, and Hologic Inc. Show Less Read more